A judge refused to throw out the lawsuit which could plausibly have broad implications for gene patenting, but seems more likely to be posturing to encourage a political/legislative solution. Ars Technica has excellent coverage here.
Update (April 26, 2010): We have more coverage here and here, and this Friday, Genetic Alliance is presenting a webinar titled "The Myriad Gene Patent Case - What Does it Mean, and Why Does it Matter?"
